Natural Agonists of Ryanodine Receptors: Structure-function Relationship and Antiarrhythmic Properties
兰尼定受体的天然激动剂:结构-功能关系和抗心律失常特性
基本信息
- 批准号:9650244
- 负责人:
- 金额:$ 46.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAcuteAdrenergic alpha-AntagonistsAffinityAgonistAmino AcidsAnimal ModelAnimalsArrhythmiaBindingBinding SitesCalciumCalcium ChannelCardiac MyocytesCardiomyopathiesCatecholaminergic Polymorphic Ventricular TachycardiaCell physiologyCellsCellular MembraneCentral Core MyopathyCharacteristicsChargeCommunitiesComplexDisadvantagedDissociationDoseEnzyme ActivationFunctional disorderGenerationsGoalsHeartHeart failureHyperactive behaviorIonsKineticsLigandsLocationMalignant hyperpyrexia due to anesthesiaMapsMetabolicMolecularMuscle CellsMyocardiumNamesPenetrationPeptidesPharmacologyPlant alkaloidPlayPropertyProteinsReceptor ActivationRecombinantsRegulationResearchRoleRyR2RyanodineRyanodine Receptor Calcium Release ChannelRyanodine ReceptorsSarcoplasmic ReticulumScorpion VenomsScorpionsSignal TransductionSkeletal MuscleSpecificitySpeedStructure-Activity RelationshipSyndromeTestingTranscriptional RegulationVenomsVentriculardipole momentexperimental studyfunctional groupimperatoxin Amultidisciplinarymutantnovelpreventprogramsreceptorreceptor functionreceptor structure functionsuccessthermostability
项目摘要
ABSTRACT
Ryanodine receptors (RyR) are sarcoplasmic reticulum Ca2+ release channels that play a critical role in
Ca2+ signaling of excitable and non-excitable cells. RyRs owe their name to the fact that they were characterized in
great part thanks to ryanodine, a plant alkaloid that binds to RyRs with high affinity and specificity. Ryanodine has
been an invaluable ligand of RyRs, but its functional effects are complex and hamper its use in cellular studies. In
search of novel ligands that could overcome some of the functional and structural disadvantages of ryanodine, we
found in the venom of selected scorpions a set of peptide ligands, termed calcins, displaying high affinity and
exquisite selectivity against RyRs. The defining characteristic of calcins is their capacity to stabilize RyR openings in
a long-lasting subconducting state. This effect is nearly analogous to that of ryanodine, but unlike ryanodine, calcins
bind rapidly to RyRs (fast association rate), freely dissociate from their binding site (reversible effect), display a dose-
and sequence-variable effect, and are amenable for derivatization without undergoing major loss in receptor affinity.
Calcins also modulate intracellular Ca2+ in intact cardiomyocytes with remarkable speed and with several degrees of
potency, thus entering the field as the first cell-penetrating peptides (CPP) RyR-specific Ca2+ mobilizer of high
dynamic range. This research program will characterize first and then exploit this novel group of peptide ligands to
unravel fundamental mechanisms of RyR function at the molecular, cellular and whole heart level. Our multidisciplinary
program, with well-defined deliverables and milestones, may be enveloped in two specific aims. In the first aim, we
will first identify and modify the structural domains of calcins involved in RyR recognition and cell penetration to
generate a group of functionally diverse CPPs capable of modulating RyR function with wide dynamic range and of
delivering cargo to the interior of cardiomyocytes. In the second aim, we will use native and mutant calcins on intact
cardiomyocytes, Langendorff-perfused working hearts and intact animals to create acute or sustained periods of RyR
hyperactivity and reveal mechanisms of RyR gating, SR Ca2+ load and Ca2+-triggered arrhythmias. These studies use
animal models of catecholaminergic polymorphic ventricular tachycardia to develop a novel paradigm for the treatment
of calcium-dependent arrhythmias; results may be applied to other cardiomyopathies where controlled unloading of
SR Ca2+ may be desirable.
抽象的
ryanodine受体(RYR)是肌质网Ca2+释放通道,在
CA2+可激发和非驱动细胞的信号传导。里尔斯的名字归功于他们的特征
大部分要归功于瑞安丁(Ryanodine),这是一种与高亲和力和特异性的Ryrs结合的植物生物碱。 ryanodine拥有
是RYR的宝贵配体,但其功能效应很复杂,并阻碍了其在细胞研究中的使用。在
搜索可以克服Ryanodine的某些功能和结构缺点的新型配体,我们
在选定蝎子的毒液中发现了一组肽配体,称为Calcins,显示高亲和力和
针对Ryrs的精美选择性。 Calcins的定义特征是它们稳定Ryr Openings的能力
持久的子导状态。这种作用几乎与瑞氨烷的作用相似,但与ryanodine不同,Calcins
与RYRS快速结合(快速关联率),从其结合位点自由解离(可逆效果),显示出剂量 -
和序列可变性的效应,并且可以衍生化,而无需受到受体亲和力的重大损失。
钙蛋白还以显着的速度和几个程度的完整心肌细胞调节细胞内Ca2+
效力,因此进入田地,作为第一个细胞穿透肽(CPP)Ryr特异性CA2+高动员
动态范围。该研究计划将首先表征
分子,细胞和整个心脏水平的RYR功能的基本机制。我们的多学科
具有明确定义的可交付成果和里程碑的计划可能包含在两个具体目标中。在第一个目标中,我们
将首先识别并修改参与RYR识别和细胞渗透到RYR识别和细胞的结构结构域
生成一组功能多样的CPP,能够调节RYR功能,并具有广泛的动态范围和
将货物运送到心肌细胞内部。在第二个目标中,我们将在完整的
心肌细胞,Langendorff丰满的工作心脏和完整的动物,以创建RYR的急性或持续时间
多动症和RYR门控,SR CA2+负载和Ca2+触发心律不齐的机制。这些研究使用
儿茶酚胺能多态性心室心动过速的动物模型,以开发一种新型范式进行治疗
钙依赖性心律不齐;结果可以应用于其他心肌病,在该心肌病中,
SR CA2+可能是可取的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hector H Valdivia其他文献
Hector H Valdivia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hector H Valdivia', 18)}}的其他基金
Rational Design from Cryo-EM Structures of High-Affinity Ryanodine Receptor Ligands Based on Natural Peptides
基于天然肽的高亲和力兰尼定受体配体的冷冻电镜结构的合理设计
- 批准号:
10729564 - 财政年份:2023
- 资助金额:
$ 46.18万 - 项目类别:
Natural Agonists of Ryanodine Receptors: Structure-function Relationship and Antiarrhythmic Properties
兰尼定受体的天然激动剂:结构-功能关系和抗心律失常特性
- 批准号:
9905552 - 财政年份:2017
- 资助金额:
$ 46.18万 - 项目类别:
2017 Muscle: Excitation-Contraction Coupling Gordon Research Conference and Gordon Research Seminar
2017肌肉:兴奋-收缩耦合戈登研究会议暨戈登研究研讨会
- 批准号:
9331041 - 财政年份:2017
- 资助金额:
$ 46.18万 - 项目类别:
Calcins as Membrane-permeable Ligands of Ryanodine Receptors
钙素作为瑞尼定受体的膜渗透性配体
- 批准号:
8301588 - 财政年份:2011
- 资助金额:
$ 46.18万 - 项目类别:
Calcins as Membrane-permeable Ligands of Ryanodine Receptors
钙素作为瑞尼定受体的膜渗透性配体
- 批准号:
8464216 - 财政年份:2011
- 资助金额:
$ 46.18万 - 项目类别:
Calcins as Membrane-permeable Ligands of Ryanodine Receptors
钙素作为瑞尼定受体的膜渗透性配体
- 批准号:
8098484 - 财政年份:2011
- 资助金额:
$ 46.18万 - 项目类别:
Calcins as Membrane-permeable Ligands of Ryanodine Receptors
钙素作为瑞尼定受体的膜渗透性配体
- 批准号:
8663945 - 财政年份:2011
- 资助金额:
$ 46.18万 - 项目类别:
Modulation of Cardiac E-C Coupling by Sorcin
Sorcin 对心脏 E-C 耦合的调节
- 批准号:
6777329 - 财政年份:2004
- 资助金额:
$ 46.18万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Strategies for Engineering Reliable Value Sets (SERVS)
工程可靠价值集 (SERVS) 的策略
- 批准号:
10417435 - 财政年份:2022
- 资助金额:
$ 46.18万 - 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
- 批准号:
10591688 - 财政年份:2022
- 资助金额:
$ 46.18万 - 项目类别:
Microglia mediate cognitive dysfunction in elderly survivors of pneumonia
小胶质细胞介导老年肺炎幸存者的认知功能障碍
- 批准号:
10354214 - 财政年份:2022
- 资助金额:
$ 46.18万 - 项目类别:
Long-term effectiveness of BPH/LUTS pharmacological therapies and using machine learning based predictive analytics to tailor treatment
BPH/LUTS 药物治疗的长期有效性,并使用基于机器学习的预测分析来定制治疗
- 批准号:
10618734 - 财政年份:2021
- 资助金额:
$ 46.18万 - 项目类别:
Elucidating sympathetic vasoconstrictor mechanisms of autonomic dysreflexia in persons with spinal cord injury
阐明脊髓损伤患者自主神经反射异常的交感血管收缩机制
- 批准号:
10404588 - 财政年份:2021
- 资助金额:
$ 46.18万 - 项目类别: